D.E. Shaw & Co
GEVA

D.E. Shaw & Co’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

D.E. Shaw & Co’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50,303
Closed -$4.91M – 4026
2015
Q1 		$4.91M Buy
+50,303
New +$5.33M 0.01% 1395
2014
Q4 		– Sell
-23,289
Closed -$1.6M – 4490
2014
Q3 		$1.6M Sell
23,289
-125
-0.5% -$8.95K ﹤0.01% 2405
2014
Q2 		$2.45M Sell
23,414
-56,670
-71% -$4.82M ﹤0.01% 2144
2014
Q1 		$6.64M Buy
+80,084
New +$7.41M 0.01% 1350

D.E. Shaw & Co's GEVA Position: Q2 2015 in Review

D.E. Shaw & Co sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 50,303 shares — an estimated $4.91M sold.

D.E. Shaw & Co first reported a position in GEVA in Q1 2014 and held it in 4 quarters. The position peaked at $6.64M in Q1 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • D.E. Shaw & Co reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 50,303 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $4.91M.
  • D.E. Shaw & Co first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 4 quarters.
  • D.E. Shaw & Co's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $6.64M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.